823 participants
Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-13
- Start Date:
- 2015-10-15
- Completion:
- 2020-07-06
Conditions
- Squamous Cell Carcinoma of the Head and Neck
Interventions
- BIOLOGICAL
- DRUG